GlassScriptPhysician profile
Clint Wood
NPI 1336357623
$1,137.74
in general payments reported to CMS, 2019-2025
13 companies · $342 in 2025
The $342 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $91.17 · 2021: $32.48 · 2022: $347 · 2023: $14.49 · 2024: $128 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $447.17 | 2020-2025 | General - Vascular Intervention, Jetstream Sc |
| Medtronic, INC. | $231.67 | 2022-2025 | Solitaire X, Micra |
| Bard Peripheral Vascular, INC. | $145.66 | 2019-2020 | |
| Microvention, INC. | $95.63 | 2022-2024 | Lvis Junior |
| Bioprotect Medical, INC. | $46.97 | 2025 | Bioprotect Balloon Implant System |
| Stryker Corporation | $32.48 | 2021 | |
| Ge Healthcare | $30.57 | 2022 | |
| Janssen Pharmaceuticals, INC | $21.06 | 2024 | Xarelto |
| Medtronic Vascular, INC. | $20.98 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.86 | 2024 | Lifevest |
| Ipsen Biopharmaceuticals, INC | $17.16 | 2019 | |
| Jazz Pharmaceuticals INC. | $15.69 | 2019 | |
| Angiodynamics, INC. | $14.84 | 2024 | Solero |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clint Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.